| Serial Number | 98243542 |
| Word Mark | SK LIFE SCIENCE LABS |
| Filing Date | Friday, October 27, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Wednesday, June 4, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 24, 2025 |
| Description of Mark | The mark consists of the letters "SK" in red stylized font and the letters "life science labs" in orange stylized font. To the top right of the "SK" portion of the mark is a design of wings. The inner portion of the wings is red, and the outer portion of the wings is orange. White is not claimed as a feature of the mark and only represents background or transparent areas. |
| Goods and Services | Medicines for human purposes for the treatment and prevention of central nervous system diseases, cancer, metabolic diseases, allergy, immunological diseases and disorders, neurological diseases and disorders, cardiac diseases and disorders, dermatological diseases and disorders, endocrinological diseases and disorders, gastroenterological diseases and disorders, hematological diseases and disorders, infectious diseases and disorders, genetic diseases and disorders, nephrological diseases and disorders, gynecological diseases and disorders, ophthalmological diseases and disorders, orthopedic diseases and disorders, otorhinolaryngological diseases and disorders, podiatric diseases and disorders, psychiatric diseases and disorders, pulmonological diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, urological diseases and disorders, and auto-immune diseases and disorders; chemical preparations for pharmaceutical purposes, namely, for the treatment and prevention of central nervous system diseases, cancer, metabolic diseases, allergy, immunological diseases and disorders, neurological diseases and disorders, cardiac diseases and disorders, dermatological diseases and disorders, endocrinological diseases and disorders, gastroenterological diseases and disorders, hematological diseases and disorders, infectious diseases and disorders, genetic diseases and disorders, nephrological diseases and disorders, gynecological diseases and disorders, ophthalmological diseases and disorders, orthopedic diseases and disorders, otorhinolaryngological diseases and disorders, podiatric diseases and disorders, psychiatric diseases and disorders, pulmonological diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, urological diseases and disorders, and auto-immune diseases and disorders; sanitary preparations for medical purposes; ferments for pharmaceutical purposes; pharmaceutical preparations, namely, immunomodulators; vitamin preparations; vaccines; nutritional additives in the nature of dietary supplements for use in foods for human consumption; bacteriological preparations for medical and veterinary use; veterinary preparations for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions |
| Indication of Colors claimed | The color(s) red and orange is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "LIFE SCIENCE LABS" |
| Goods and Services | Technical project studies, namely, conducting clinical trials for others; development of new technology for others in the field of biotechnology; biotechnology research; biotechnology services, namely, research and development in the biotechnology fields; biotechnology services, namely, providing information on the subject of scientific research in the field of biotechnology; biochemical analysis; research and development of new products for others; research relating to pharmaceuticals; product development consultation, namely, analysis and evaluation of medical product development; testing, inspection or research of pharmaceuticals; pharmaceutical product evaluation; medical research; chemical research; development and test of chemical production methods |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 6, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 6, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SK Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Seoul 03188 KR |
| Event Date | Event Description |
| Tuesday, November 7, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, October 31, 2023 | NEW APPLICATION ENTERED |
| Monday, November 6, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 29, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, February 7, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 7, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 7, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 2, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 3, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, June 1, 2024 | SUSPENSION LETTER WRITTEN |
| Sunday, September 29, 2024 | ASSIGNED TO EXAMINER |
| Friday, November 15, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, November 15, 2024 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| Friday, November 15, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, November 15, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, November 15, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Saturday, June 1, 2024 | LETTER OF SUSPENSION E-MAILED |
| Saturday, June 1, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, December 17, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 17, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 17, 2024 | ASSIGNED TO LIE |
| Monday, March 3, 2025 | INQUIRY TO SUSPENSION E-MAILED |
| Monday, March 3, 2025 | ASSIGNED TO EXAMINER |
| Monday, March 3, 2025 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Monday, March 3, 2025 | SUSPENSION INQUIRY WRITTEN |
| Wednesday, May 14, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 14, 2025 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, May 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, May 15, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, May 30, 2025 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |